-
EP1124961
European procedure
Extract from the Register of European Patents
EP About this file: EP1124961
| EP1124961 - THROMBOPOIETIC COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.10.2007 Database last updated on 07.03.2026 | Most recent event Tooltip | 18.06.2010 | Correction of patent specification | published on 21.07.2010 [2010/29] | Applicant(s) | For all designated states Kirin-Amgen Inc. c/o Amgen Inc., One Amgen Center Drive Thousand Oaks, CA 91320 / US | [2007/34] |
| Former [2006/50] | For all designated states AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1799 / US | ||
| Former [2002/44] | For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 / US | ||
| Former [2001/34] | For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320-7119 / US | Inventor(s) | 01 /
LIU, Chuan-Fa 1425 Clover Creek Drive Longmont, CO 80503 / US | 02 /
FEIGE, Ulrich 3117 Deer Valley Avenue Newbury Park, CA 91320 / US | 03 /
CHEETHAM, Janet 1695 East Valley Road Montecito, CA 93108 / US | [2001/34] | Representative(s) | Richardson, Kate Forrester & Boehmert, Pettenkoferstrasse 20-22 80336 München / DE | [N/P] |
| Former [2001/34] | Richardson, Kate Forrester & Boehmert, Franz-Joseph Strasse 38 80801 München / DE | Application number, filing date | 99970998.3 | 22.10.1999 | [2001/34] | WO1999US24834 | Priority number, date | US19980105348P | 23.10.1998 Original published format: US 105348 P | [2001/34] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0024770 | Date: | 04.05.2000 | Language: | EN | [2000/18] | Type: | A2 Application without search report | No.: | EP1124961 | Date: | 22.08.2001 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.05.2000 takes the place of the publication of the European patent application. | [2001/34] | Type: | B1 Patent specification | No.: | EP1124961 | Date: | 13.12.2006 | Language: | EN | [2006/50] | Type: | B9 Corrected patent specification | No.: | EP1124961 | Date: | 21.07.2010 | [2010/29] | Search report(s) | International search report - published on: | EP | 14.09.2000 | Classification | IPC: | C12N15/19, C07K14/52, C12N5/10, C12N1/21, A61K38/19, A61P7/06 | [2001/34] | CPC: |
C07K14/524 (EP,US);
C07K14/52 (KR);
A61P43/00 (EP);
A61P7/00 (EP);
A61P7/04 (EP);
A61P7/06 (EP);
C07K7/06 (EP,US);
C07K7/08 (EP,US);
A61K38/00 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/34] | Extension states | AL | 23.04.2001 | LT | 23.04.2001 | LV | 23.04.2001 | MK | 23.04.2001 | RO | 23.04.2001 | SI | 23.04.2001 | Title | German: | THROMBOPOIETIN SUBSTITUTE | [2006/25] | English: | THROMBOPOIETIC COMPOUNDS | [2001/34] | French: | COMPOSES THROMBOPOIETIQUES | [2001/34] |
| Former [2001/34] | DIMERE THROMBOPOIETIN SUBSTITUTE, DIE AN DEN MP1 REZEPTOR BINDEN UND THROMBOPOIEITISCHE AKTIVITÄT BESITZEN | Entry into regional phase | 23.04.2001 | National basic fee paid | 23.04.2001 | Designation fee(s) paid | 23.04.2001 | Examination fee paid | Examination procedure | 23.05.2000 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 23.04.2001 | Examination requested [2001/34] | 07.10.2003 | Despatch of a communication from the examining division (Time limit: M06) | 16.04.2004 | Reply to a communication from the examining division | 11.05.2004 | Despatch of a communication from the examining division (Time limit: M08) | 14.01.2005 | Reply to a communication from the examining division | 14.06.2006 | Communication of intention to grant the patent | 24.10.2006 | Fee for grant paid | 24.10.2006 | Fee for publishing/printing paid | Divisional application(s) | EP06022333.6 / EP1783222 | EP10011689.6 / EP2319928 | Opposition(s) | 14.09.2007 | No opposition filed within time limit [2007/47] | Fees paid | Renewal fee | 11.10.2001 | Renewal fee patent year 03 | 15.10.2002 | Renewal fee patent year 04 | 14.10.2003 | Renewal fee patent year 05 | 14.10.2004 | Renewal fee patent year 06 | 12.10.2005 | Renewal fee patent year 07 | 12.10.2006 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [YD] CWIRLA S E ET AL: "PEPTIDE AGONIST OF THE THROMBOPOIETIN RECEPTOR AS POTENT AS THE NATURAL CYTOKINE", SCIENCE,US,AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, vol. 276, 13 June 1997 (1997-06-13), pages 1696 - 1699, XP002067303, ISSN: 0036-8075 [YD] 1-34 * see page 1698, first column, scond paragraph * DOI: http://dx.doi.org/10.1126/science.276.5319.1696 | [AD] WRIGHTON N C ET AL: "INCREASED POTENCY OF AN ERYTHROPOIETIN PEPTIDE MIMETIC THROUGH COVALENT DIMERIZATION", NATURE BIOTECHNOLOGY,US,NATURE PUBLISHING, vol. 15, 1 November 1997 (1997-11-01), pages 1261 - 1265, XP000749524, ISSN: 1087-0156 [AD] 1 * see page 1262:"A chemically defined dimeric form of EMP1 with increased affinity and biological potency" * DOI: http://dx.doi.org/10.1038/nbt1197-1261 |